Mitigating propensity score model misspecification with multiply robust weights when leveraging external data.

J Biopharm Stat

Department of Biostatistics, NHC Key Laboratory for Health Technology Assessment, Key Laboratory of Public Health Safety of Ministry of Education, School of Public Health, Fudan University, Shanghai, China.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Propensity score-integrated Bayesian dynamic borrowing methods offer an effective approach for covariate adjustment when using external data to augment randomized controlled trials (RCTs). However, identifying the correct propensity score model can be challenging due to unknown treatment selection processes, potentially leading to model misspecification and biased estimates. To improve robustness to model misspecification, we propose an innovative Bayesian inference procedure that incorporates multiply robust weights into the construction of informative power priors. Specifically, we specify a set of candidate propensity score models to derive multiply robust weights, balancing covariates between the current data and external data. The weighted external data is then incorporated into the analysis using a Bayesian power prior method. We further extend this approach to leverage multiple external datasets. Simulation studies indicate that when the set of postulated propensity score models include a correctly specified model, the proposed method achieves desirable operating characteristics, including low bias, low root mean squared error (RMSE), controlled type I error rate at the predetermined nominal level, and high statistical power. This method also provides a robust strategy for researchers who may have a difficult time developing or selecting a single propensity score model.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10543406.2025.2547593DOI Listing

Publication Analysis

Top Keywords

propensity score
20
external data
16
score model
12
model misspecification
12
multiply robust
12
robust weights
12
score models
8
model
6
score
5
external
5

Similar Publications

Background: The optimal number of examined lymph nodes (ELN) for accurate staging and prognosis for esophageal cancer patients receiving neoadjuvant therapy remains controversial. This study aimed to evaluate the impact of ELN count on pathologic staging and survival outcomes and to develop a predictive model for lymph node positivity in this patient population.

Methods: Data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database and a multicenter cohort.

View Article and Find Full Text PDF

Study Design: Retrospective cohort.

Objective: To evaluate the impact of having a history of obstructive sleep apnea (OSA) in patients undergoing anterior cervical discectomy and fusion (ACDF) on postoperative outcomes.

Background: With an aging population and rates of obesity increasing, comorbidities that influence patient safety are increasingly common.

View Article and Find Full Text PDF

Background: Social support can have health benefits but may also pose risks for the elderly, particularly those facing conflicts and network disruptions. Understanding the short and long-term mental health effects, especially in elderly individuals with chronic illnesses, is crucial due to global depression concerns. Yet, research is limited, with gaps in exploring different social disruption scenarios and lacking comprehensive multi-period data analysis.

View Article and Find Full Text PDF

Background Hyperuricemia (HUA) frequently coexists with coronary artery disease (CAD) and is linked to adverse cardiovascular outcomes. The long-term impact of urate-lowering therapy (ULT) on clinical outcomes, including all-cause mortality and major adverse cardiovascular events (MACEs), in CAD patients after percutaneous coronary intervention (PCI) has not been determined. That was the aim of this study.

View Article and Find Full Text PDF

Aim    To analyze the efficacy and cost-effectiveness of various options of antithrombotic therapy in patients with type 2 diabetes mellitus (T2DM) after acute coronary syndrome (ACS), based on the results of a one-year follow-up.Material and methods    The article presents features of various antithrombotic therapies in patients with T2DM after ACS from the standpoint of efficacy and cost-effectiveness in real clinical practice based on the materials of the ORACLE II open prospective observational study (2014-2017). The data of 368 patients were divided into three groups based on the selected antithrombotic therapy.

View Article and Find Full Text PDF